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Available online 22 July 2019Protein may play a beneficial role in the prevention of bone loss and in slowing down osteoporosis. The ef-
fect of dietary protein may be different in older adults compared to younger adults, since this population has
a greater need for protein. The aim of this systematic review andmeta-analysis was to investigate the impact
of a dietary protein intake above the Recommended Dietary Allowance (RDA) of 0.8 g/kg body weight/day
from any source on Bone Mineral Density (BMD)/Bone Mineral Content (BMC), bone turnover markers,
and fracture risk in older adults compared to a lower dietary protein intake. A systematic search was con-
ducted through October 2018 in 3 databases: CENTRAL, MEDLINE, and EMBASE. We included all prospective
cohort studies and Randomized Controlled Trials (RCTs) among adults aged ≥65 years that examined the re-
lation between protein intake on bone health outcomes. Two investigators independently conducted ab-
stract and full-text screenings, data extractions, and risk of bias assessments. Authors were contacted for
missing data. After screening of 523 records, twelve cohort studies and one RCT were included. Qualitative
evaluation showed a positive trend between higher protein intakes and higher femoral neck and total hip
BMD. Meta-analysis of four cohort studies showed that higher protein intakes resulted in a significant de-
crease in hip fractures (pooled hazard ratio: 0.89; 95% confidence interval: 0.84, 0.94). This systematic re-
view supports that a protein intake above the current RDA may reduce hip fracture risk and may play a
beneficial role in BMD maintenance and loss in older adults.
© 2019 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural
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Bone health outcomes of interest.
Outcome Sites or markers
BMC Total body
BMD Total body, total hip, femoral neck, lumbar spine
Bone turnover
markers
Alkaline phosphatase, bone alkaline phosphatase, bone-specific
alkaline phosphatase, collagen type I cross-linked C-terminal
telopeptide, collagen type I cross-linked N-terminal
telopeptide, C-terminal type 1 procollagen, N-terminal type 1
procollegen, deoxypyridinoline, hydroxyproline, pyridinoline,
osteocalcin
Fracture All sites1. Introduction
Osteoporosis is an increasing public health problem worldwide
[1]. The prevalence in nine industrialized countries is estimated at
9–38% for women and 1–8% for men, affecting up to 49 million peo-
ple [2]. The rising prevalence of osteoporosis leads to an increase in
the number of falls and fractures, which in turn affects mortality
and morbidity, and increases the economic burden [1]. Protein may
play a role in the prevention of bone loss and in slowing down oste-
oporosis [3].
An adequate intake of dietary protein is important for bone ac-
quisition and maintenance. Older adults may become protein mal-
nourished due to an inadequate intake of protein and a reduced
ability to use available protein, because of age-related changes in
metabolism, immunity, and hormone levels and sensitivity [4,5]. At
the same time there is a greater need for protein [5]. The current rec-
ommended dietary allowance (RDA) for protein is 0.8 g/kg body
weight/day [6]. For the preservation of muscle function, evidence
supports a protein intake of 1.0–1.2 for healthy older adults and
1.2–1.5 g/kg body weight/day for older adults suffering from acute
or chronic illnesses [7].
Over the past years, the relation between dietary protein intake and
bone health has received much attention. Safety concerns of a high die-
tary protein intake have been raised, but beneficial effects on bone
health have also been found. As yet, several systematic reviews and
meta-analyses [8–11] have been published investigating the effect of di-
etary protein intake on bone health. All of these publications pooled co-
hort studies and trials over a wide age range with specific exclusion
criteria to find beneficial effects of protein intake on BoneMineral Den-
sity (BMD), Bone Mineral Content (BMC), bone turnover markers, and/
or fracture risk. Some reviews include trials that have an intervention
duration of b6 months [8,10]. However, it is questionable if dietary in-
terventions can already lead to a measurable change in BMD within
such a short time span. To get a reliable estimate of the impact on
changes in BMD, a minimum intervention duration of 6 months seems
appropriate [12].
An expert consensus paper from 2018 summarized the systematic
reviews and meta-analyses looking at the effects of dietary protein on
bone health in adults [3]. It states that protein intakes above the RDA,
in combination with an adequate calcium intake, is associated with
higher BMD, a lower rate of bone loss, and a modestly reduced fracture
risk. Furthermore, it was not proven that the acid load caused by a high
protein intake is harmful for bone health.
None of the above reviews focussed on older adults (age of 65 years
and older) specifically. The effect of dietary protein may be different in
older adults compared to adults, since this population has a greater
need for protein. The aim of this systematic review and meta-analysis
was to investigate the impact of a dietary protein intake above the
RDA of 0.8 g/kg body weight/day from any source on BMD/BMC, bone
turnover markers, and fracture risk in older adults compared to a
lower dietary protein intake.2. Methods
The Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement is followed in reporting this systematic
review [13].
2.1. Data Sources and Searches
A systematic search was conducted through October 29, 2018, in 3
databases: CENTRAL (http://www.thecochranelibrary.com), MEDLINE
(https://www.ncbi.nlm.nih.gov/pubmed/), and EMBASE (https://
www.ovid.com/). The searches were limited to the English language,
and prospective cohort and human intervention studies that examined
the relations of protein intake (food or supplemental sources) on bone
health outcomes of interest. The search strategy per database is pre-
sented in Supplementary Table A1.
2.2. Study Eligibility Criteria
We included all prospective cohort studies and randomized con-
trolled trials (RCTs) among older adults aged ≥65 years that examined
the relation between protein intake from any source on several bone
health outcomes (Table 1). Studies including both young and older indi-
vidualswere still included if stratificationwas performed. Studies had to
have an intervention duration of at least 6months. Studies enrolling ex-
clusively subjects with a diagnosed disease or where N20% of the base-
line population was diagnosed with a disease were excluded.
Furthermore, studies were excluded if they were designed to examine
outcomes in response to protein type but not protein quantity and if
protein was supplemented in the form of soy isoflavone. The reason
for the latter is that these plant oestrogens present in soy can indepen-
dently have an effect on bone loss [14]. Also studies designed for weight
loss were excluded.
2.3. Study Selection Process
First, citation duplicates across the 3 literature searches were re-
moved. Second, titles were screened by a single investigator to excludeNote. BMC = Bone Mineral Content; BMD = Bone Mineral Density.
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were then independently screened by 2 investigators.When an abstract
was regarded as potentially relevant, full-text articles were retrieved
and independently screened by 2 investigators based on study eligibility
criteria. All abstract and full-text articles screening conflicts were re-
solved through discussion between the 2 investigators and a final deci-
sion was made by the consensus of the entire research team.
2.4. Data Extraction
To capture data of interest from the eligible studies, a data extrac-
tion sheet was created in Excel. One investigator extracted the data
from all studies, which was reviewed and confirmed by another in-
vestigator. The following items were extracted: study characteris-
tics, baseline population characteristics, intervention details,
relevant outcomes and their assessment methods, data details (in-
cluding dropouts), confounders and effect modifiers used in statisti-
cal analysis, and results.
2.5. Risk of Bias in Individual Studies
The Newcastle-Ottawa Scale (NOS) was used to assess risk of bias of
included prospective cohort studies [15]. For intervention studies, the
Cochrane Collaboration's tool for assessing risk of bias was used to as-
sess internal validity [16]. This tool addresses risk of selection bias, per-
formance bias, detection bias, attrition bias, reporting bias, and other
potential biases. Two investigators independently assessed the risk of
bias in included studies. Disagreements were discussed among the re-
search team and resolved via group consensus.
2.6. Data Synthesis
All included studies were summarized in narrative form and in ta-
bles. Items of the summary tables include study characteristics (first au-
thor, publication year, cohort name), participant characteristics,
baselinemean age or age range, exposure assessment, follow-up period,
and outcomes. Summary tables were organized by study type (cohort
and RCT). Resultswere qualitatively and, if possible, quantitatively sum-
marized by study type and outcome of interest. Meta-analysis was per-
formed using R (v3.5.3; package meta) [17].
2.6.1. Qualitative Synthesis
Quality of the evidence was judgedwith the use of a grading system
developed by the GRADE collaboration [18]. According to the GRADE
approach, evidence was graded as ‘High’, ‘Moderate’, ‘Low’, or ‘Very
Low’ depending on several criteria. Quality of evidence was down-
graded based on five GRADE categories: risk of bias, imprecision, incon-
sistency, indirectness, and publication bias [19]. Quality was graded
upwards when effects were sufficiently large, when all plausible biases
would underestimate the effect, or when there was a dose-response
gradient [20].
2.6.2. Quantitative Synthesis
If sufficient data were available and homogeneity in terms of par-
ticipants, interventions and outcomes between studies were reason-
able, a meta-analysis was conducted. Authors of relevant articles
were contacted if required data were not reported. The methods de-
scribed in the Cochrane Handbook for conducting meta-analyses
was followed [16]. Results were pooled using a random-effects
meta-analysis, with standardized mean differences for continuous
outcomes and risk ratios (RR) or hazard ratios (HR) for binary out-
comes. The extent of statistical heterogeneity was quantified using
both the chi-squared test and the I-squared statistic. An I-squared
value N50% was used as a threshold for indicating substantial statis-
tical heterogeneity [16]. Random-effects model was used whenstudies were drawn from populations that differ from each other in
such a way that it could influence the effect estimate. When hetero-
geneity was not present, a fixed-effect model was used. Sensitivity
analyses were performed to explore the impact of excluding studies
that were judged to be at high risk of bias and to detect the influence
of a single study on the overall estimate.3. Results
The search yielded 659 citations and two additional articles [21,22]
were identified by searching in the reference lists of the other articles
included in the analyses. After removal of 138 duplicates and exclusion
of 53 articles because the title made clear that it was not a prospective
cohort study or RCT, 470 articles were identified for dual abstract
screening. A total number of 84 articles were identified for full-text
screening, of which 13 were included for data extraction (12 prospec-
tive cohort studies and 1 RCT; Fig. 1). The characteristics of the included
studies are shown in Table 2 and Table 3.3.1. Quality of Evidence
Risk of bias assessment using NOS in selected prospective cohort
studies is presented in Table 4. Risk of bias was classified as high
(score 1–3), potential limitations (score 4–6), or low (score 7–9). How-
ever, one study with a score of 4 was classified as having a high risk of
bias due to a substantial large loss of follow-up (42.5%) [31]. Six cohort
studies were classified as having a low risk of bias, five had potential
limitations, and one study had a high risk of bias.With respect to adjust-
ment of important confounders, 1 point was given if they controlled for
age, gender, weight or BMI, energy intake, physical activity, smoking, al-
cohol, vitamin D, and calcium. Another point was given if family history
of osteoporosis, fractures, (certain) illnesses, and (certain) drugs
were included. Only one study took all those confounders into account
[24]. Nine studies adjusted for a part of the relevant confounders
[21–23,25,26,29,30,32,33] and in three studies adjustment was inade-
quate [27,28,31]. The dropout rate was not clear in one cohort study
[27] and another study stated that the rate was around 10% per
4 years with a total follow-up of 32 years [21]. Dropout rates were
high (≥20%) in five studies varying from 24.7% to 81.2%, which (poten-
tially) leads to attrition bias [25,28,29,31,32]. In the other five cohort
studies, rates varied from 2.0% to 12.1%. Publication bias could not be
assessed, because the numbers of studies in the meta-analysis were
too small.
Using the Cochrane Collaboration's tool, overall risk of bias in the se-
lected intervention study [33] was classified as ‘low to some concerns’
(Table 5). Those concerns were raised with respect to attrition and
reporting bias. The dropout rate was 10.5% after 1 year and 18.3% after
2 years. An expected dropout rate of 30% was taken into account in
the sample size calculation. Furthermore, there were no significant dif-
ferences between the protein and control group in the number of peo-
ple lost to follow-up.
According to the GRADE approach, evidence from observational
studies should be rated as low quality (Table 6). Five cohort studies
reported the protein intake per a defined unit increase in energy-
adjusted protein intake (dose-response gradient). In absence of seri-
ous limitations in other categories, three of those cohort studies
were rated up one level to moderate quality with respect to their
BMD and fracture outcomes [24,29,30]. Quality of evidence for the
outcomes total body BMC and bone turnover markers was rated
down to ‘very low’ due to risk of bias, imprecision, and limited num-
ber of studies. In addition, quality of evidence for total fractures and
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3.2.1. BMC–Total Body
Two studies assessed the effect of protein intake on total body BMC
and showed different results [29,31]. Meng et al. [31] found that post-
menopausal women with a protein intake above the RDA (N1.6 g/kg
bw/d) had a significant 5.3% higher whole body BMC compared to
women with a low protein intake (b0.8 g/kg bw/d) after 5 years of
follow-up. Isanejad et al. [29] found that protein intake was not signifi-
cantly associated with total body BMC over 3 years of follow-up.3.2.2. BMD–Total Body
Four studies assessed the effect of protein intake on total body BMD,
of which one saw a beneficial effect [26] and three found no significant
effects [23,29,32]. Dawson-Hughes et al. [26] found that the highest
tertile of protein intake (18.2–29.1% of total energy; estimated mean
1.17 g/kg bw/d) was associated with significantly higher total body
BMD after 3 years of follow-up compared to the lowest tertile of protein
intake (9.6–15.5% of total energy; estimated mean 0.96 g/kg bw/d;
figure-derived: mean percent change 0.6% vs -0.2%, respectively). This
effectwas seen in a groupwho took calciumand vitaminD supplements
for 3 years, but no association was found in the placebo group. Beasley
et al. [23] found that each 20% increase in calibrated protein intake
was associated with a non-significant increase in total body BMD inwomen aged 65 and 75 years at baseline after 3 years of follow-up.
Isanejad et al. [29] found that protein intake was not significantly asso-
ciated with total body BMD over 3 years of follow-up and Rapuri et al.
[32] found no differences in total body BMD between four quartiles of
protein intake above the RDA (0.95, 0.94, 0.98, 0.99 g/kg bw/d; 13.3,
15.2, 16.7, 19.5% of energy intake) after 3 years of follow-up.3.2.3. BMD–Total Hip
Five studies assessed the effect of protein intake on total hip BMD, of
which two found beneficial effects [27,30] and three found no signifi-
cant effects [23,25,32]. Devine et al. [27] found that women with a
protein intake above the RDA (N1.6 g/kg bw/d) had a significantly
higher hip BMD compared to women with a low protein intake
(b0.8 g/kg bw/d) after 1 year of follow-up (figure-derived: mean 824
vs 798 mg/cm2, respectively). Langsetmo et al. [30] showed that a
higher protein intake (each standard deviation (SD) increase in total en-
ergy from protein intake) was associated with higher hip BMD in men
after 10.5–11.2 years of follow-up (beta = 0.06, standard error =
0.01). On the other hand, Beasley et al. [23] found that each 20% increase
in calibrated protein intake was associated with a non-significant in-
crease in hip BMD in women aged 65 and 75 years at baseline after
3 years of follow-up. Chan et al. [25] found that protein intake was not
associated with % change in hip BMD in men and women after 4 years
of follow-up. Rapuri et al. [32] found no differences in hip BMDbetween
Table 2








or age range (y)
Exposure
assessment
Mean protein intakea Follow-up (y) Relevant
outcomes
Effect sizesb












0.52, 0.75, 0.92, 1.11, 1.50 (quantiles,
whole sample)
6 TB BMD Per 20% increase in protein intake:
65 y: mean 0.003 (0.001, 0.005) ns
75 y: mean 0.003 (0.001, 0.007) ns
Hip BMD 65 y: mean 0.003 (0.001, 0.005) ns
75 y: mean 0.004 (0.001, 0.007) ns
Any fracture 65 y: HR 0.99 (0.96, 1.01) ns 75 y: HR
0.96 (0.91, 1.02) ns
Hip fracture 65 y: HR 0.91 (0.82, 0.99) ns
75 y: HR 0.92 (0.83, 1.02) ns
Cauley, 2016 [24] Osteoporotic
Fractures in Men
Study (US)





No fracture: 16.1%; fracture: 15.3% of
EI
8.6 Hip fracture Per SD increase in protein intake (2.9% of
EI):
HR 0.82 (0.69, 0.97) pb0.05








FFQ Men 88.8, women 65.7 g/d.
Men 1.42; women 1.19 g/kg bw/d
(estimated values)
4 Per unit increase in energy-adjusted
protein intake:
Hip BMD Men: B -0.007 SE 0.005 p 0.147
Women: B 0.003 SE 0.009 p 0.744
FN BMD Men: B -0.013 SE 0.008 p 0.088
Women: B 0.010 SE 0.013 p 0.416
Dawson-Hughes,
2002 [26]









9.6–15.5, 15.5–18.2, 18.2–29.1% of EI
(tertiles). Supplemented: 0.96, 1.07,
1.17; placebo: 0.90, 1.08, 1.20 g/kg
bw/d (estimated values)
3 Supplemented group protein T3 vs T1:
TB BMD NR, less loss/gain p 0.042
FN BMD NR, less loss/gain p 0.011
Spine BMD NR, no difference ns
Osteocalcin NR, no difference ns
N-telopeptide NR, no difference ns
Devine, 2005 [27] - (Australia) Women N70 y 1077 75(3) ACCV
semi-quantitative
FFQ
b0.84, 0.84–1.6, N1.6 (tertiles) 1 Hip BMD Protein T3 vs T1:
NR, higher pb0.05
FN BMD NR, higher pb0.05
Fung, 2017 [21] Nurses' Health Study
& Health Professionals
Follow-Up Study (US)












Women 14.3, 18.6, 24.4% of EI; men
14.2, 18.3, 23.4% of EI (whole
sample).
Women 0.88, 1.12, 1.41; men 0.87,
1.12, 1.40 g/kg bw/d (estimated
values)
32 Hip fracture Protein Q5 vs Q1:
Women 65–75 y: RR 0.92 (0.71, 1.18)
Women 75+ y: RR 0.91 (0.69, 1.20)
Men 65–75 y: RR 0.59 (0.33, 1.07)
Men 75+ y: RR 0.77 (0.51, 1.15)
Hannan, 2000 [28] Framingham
Osteoporosis Study
(US)





4 FN BMD Protein Q4 vs Q1:
Mean − 2.32(0.74)% vs −4.61(0.70)%
pb0.001
LS BMD Mean − 1.11(1.10)% vs −3.72(0.97)%
pb0.05




Women ≥65 y 750/544 68.1(1.9), 65–72 3 d food records 0.79, 0.90, 0.96, 1.18 (quartiles) 3 TB BMC Per unit increase in energy-adjusted
protein intake:
B -0.16 SE 30.04 p 0.159
TB BMD B 0.04 SE 0.01 p 0.507
FN BMD B -0.01 SE 0.01 p 0.918






Men ≥65 y 5994/5875 73.6(5.9) Modified Block
FFQ
0.67, 0.75, 0.83, 0.93 (quartiles) 10.5–11.2 Hip BMD Per SD increase in protein intake (2.9% of
EI):
B 0.06 SE 0.01 pb0.001
Spine fracture HR 1.06 (0.92, 1.22) p 0.45
Hip fracture HR 0.84 (0.73, 0.95) p 0.01
Meng, 2009 [31] - (Australia) Women 70–85 y 1500/862 74.9(2.6) ACCV quantitative
FFQ
b0.84, 0.84–1.6, N1.6 (tertiles) 5 TB BMC Protein T3 vs T1:
5.3% higher pb0.05
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bw/d; 13.3, 15.2, 16.7, 19.5% of energy intake) after 3 years of follow-up.
3.2.4. BMD–Femoral Neck
Six studies assessed the effect of protein intake on femoral neck
BMD, half of them showed beneficial effects [26–28] and the other
half showed no significant effects [25,29,32]. Dawson-Hughes et al.
[26] found that highest tertile of protein intake (18.2–29.1% of total en-
ergy; estimatedmean 1.17 g/kg bw/d)was associatedwith significantly
higher femoral neck BMD after 3 years of follow-up compared to the
lowest tertile of protein intake (9.6–15.5% of total energy; estimated
mean 0.96 g/kg bw/d; figure-derived: mean percent change 2.5% vs
-0.4%, respectively). This effect was seen in a group who took calcium
and vitamin D supplements for 3 years, but no association was found
in the placebo group. Devine et al. [27] found thatwomenwith a protein
intake above the RDA (N1.6 g/kg bw/d) had a significantly higher
femoral neck BMD compared to women with a low protein intake
(b0.8 g/kg bw/d) after 1 year of follow-up (figure-derived: mean 702
vs 679 mg/cm2, respectively). Hannan et al. [28] showed that men and
women with a protein intake above the RDA (1.24–2.78 g/kg bw/d)
had significantly less femoral neck BMD loss than those with a protein
intake below the RDA (0.21–0.71 g/kg bw/d) after 4 years of follow-
up (mean percent change -2.32% vs -4.61%). With regard to the studies
showing no effect, Chan et al. [25] found that protein intake was not as-
sociated with % change in femoral neck BMD in men and women after
4 years of follow-up. Isanejad et al. [29] found that protein intake was
not significantly associated with femoral neck BMD over 3 years of
follow-up and Rapuri et al. [32] found no differences in femoral neck
BMD between four quartiles of protein intake above the RDA (0.95,
0.94, 0.98, 0.99 g/kg bw/d; 13.3, 15.2, 16.7, 19.5% of energy intake)
after 3 years of follow-up.
3.2.5. BMD–(Lumbar) Spine
Four studies assessed the effect of protein intake on (lumbar)
spine BMD, of which one found a beneficial effect [28], one found
a negative effect [29], and two found no significant effects
[26,32]. Hannan et al. [28] found a beneficial effect, they showed
that men and women with a protein intake above the RDA (1.24–
2.78 g/kg bw/d) had significantly less lumbar spine BMD loss
than those with a protein intake below the RDA (0.21–0.71 g/kg
bw/d) after 4 years of follow-up (mean percent change −1.11%
vs −3.72%). On the contrary, Isanejad et al. [29] found that in
women with protein intakes ranging from 0.79 to 1.18 g/kg bw/d,
protein was significantly negatively associated with total body
BMD over 3 years of follow-up (beta = −0.31, standard error =
0.01). Dawson-Hughes et al. [26] found no association between
the protein tertile of 18.2–29.1% of total energy (estimated mean
1.17 g/kg bw/d) vs 9.6–15.5% of total energy (estimated mean
0.96 g/kg bw/d) for spine BMD after 3 years of follow-up. In addi-
tion, Rapuri et al. [32] found no differences in spine BMD between
four quartiles of protein intake above the RDA (0.95, 0.94, 0.98,
0.99 g/kg bw/d; 13.3, 15.2, 16.7, 19.5% of energy intake) after
3 years of follow-up.
3.2.6. Bone Turnover Markers
Two studies assessed the effect of protein intake on the bone turn-
over markers osteocalcin and N-telopeptide [26,32]. Dawson-Hughes
et al. [26] found no association between the highest and lowest protein
tertile (18.2–29.1% vs 9.6–15.5% of total energy; estimated means
1.17 vs 0.96 g/kg bw/d) for both serum osteocalcin and urinary N-
telopeptide cross-links after 3 years of follow-up. Rapuri et al. [32]
also found no differences in serum osteocalcin and urinary N-
telopeptides between four quartiles of protein intake above the RDA
(0.95, 0.94, 0.98, 0.99 g/kg bw/d; 13.3, 15.2, 16.7, 19.5% of energy intake)
after 3 years of follow-up.
Table 3




















2.1 g (skim milk);
after 2y: 1.1 g/kg
bw/d
30 g (skim milk + whey protein
isolate); after 2y: 1.4 g/kg bw/d
2 Hip BMD Mean change(SD)
protein vs placebo
(mg/cm2):
After 1y: −8.3(21) vs
−5.1(22) p 0.31
After 2y: −10.8(25) vs
−8.2(22) p 0.46
FN BMD After 1y: −5.7(22) vs
−2.6(24) p 0.34
After 2y: −8.7(26) vs
−7.9(27) p 0.84
Note. BMD = Bone Mineral Density; NR = Not Reported; ns = not significant; RCT = Randomized Controlled Trial; SD = Standard Deviation.
Table 4
Newcastle - Ottawa quality assessment scale for selected cohort studies.




















Beasley, 2014 [23] 1 1 1 0 1 1 1 1 7 Low
Cauley, 2016 [24] 1 1 0 1 2 1 1 1 8 Low




0 1 0 1 1 1 1 1 6 Low
Devine, 2005 [27] 1 1 0 0 0 1 1 0 4 Some
concerns
Fung, 2017 [21] 0 1 0 1 1 1 1 1 6 Some
concerns
Hannan, 2000 [28] 1 1 0 1 0 1 1 0 5 Some
concerns
Isanejad, 2017 [29] 1 1 1 1 1 1 1 0 7 Low
Langsetmo, 2017 [30] 1 1 0 0 1 1 1 1 6 Low
Meng, 2009 [31] 1 1 0 0 0 1 1 0 4 High
Misra, 2011 [22] 1 1 0 1 1 1 1 1 7 Low
Rapuri, 2003 [32] 1 1 1 0 1 1 1 0 6 Some
concerns
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Only Beasley et al. [23] looked at total fractures and found that each
20% increase in calibrated protein intake was associated with a non-
significant decrease in risk of total fractures in women aged 65 and
75 years at baseline after 3 years of follow-up.
With regard to risk of spine fracture specifically, only Langsetmo
et al. [30] studied this outcome and found no association between a
higher protein intake (each SD increase in total energy from protein
intake) and risk of spine fracture in men after 10.5–11.2 years of
follow-up.
More often investigated was the risk of getting a hip fracture. Five
studies assessed the effect of protein intake on hip fracture risk, of
which four showed a beneficial effect [21,22,24,30] andone foundnoef-
fect [23]. Cauley et al. [24] showed that each SD increase in total energy
fromproteinwas associatedwith an 18%decrease in risk of hip fractures
in men after 8.6 years of follow-up. In the same cohort population but
after 10.5–11.2 years of follow-up, Langsetmo et al. [30] found a signif-
icant association between each SD increase in total energy from protein
intake and a decreased hip fracture risk of 16%. Fung et al. [21] showed
an 8% lower risk of hip fractures inwomen aged 65–75 years consuming
1.4 g protein/kg bw/d (estimated value, 24.4% of energy intake) com-
pared to a protein intake of 0.9 g/kg bw/d (estimated value, 14.3% of en-
ergy intake) and a 9% lower risk inwomen aged ≥75 years after 32 years
of follow-up. Inmen aged 65–75 years, a 41% lower hip fracture riskwas
found between the highest vs lowest protein tertile (23.4% vs 14.2% of
energy intake, estimated mean 1.4 vs 0.9 g/kg bw/d) and this reduction
in risk was 23% in men aged ≥75 years. Misra et al. [22] found that a
mean protein intake above the RDA (three quartiles: 59.6, 67.7,
82.7 g/d; estimated 0.88, 1.00, 1.22 g/kg bw/d) was significantly posi-
tively associated with a decreased hip fracture risk of 37% after
11.6 years of follow-up compared to a mean protein intake below the
RDA (46.5 g/d; estimated 0.69 g/kg bw/d). However, Beasley et al. [23]
found that each 20% increase in calibrated protein intakewas associated
with a non-significant decrease in risk of hip fractures in women aged
65 and 75 years at baseline after 3 years of follow-up (9% and 8%
respectively).
3.3. RCTs
No eligible RCTs were found investigating the effect of dietary pro-
tein intake on BMC, total body and lumbar spine BMD, and bone turn-
over markers. Only one RCT with total hip and femoral neck BMD as
outcome was suitable for inclusion [33]. Zhu et al. [33] investigated
the effect of a high-protein drink containing 30 g of protein compared
to a placebo drink with 2.1 g of protein. Protein intake after 2 years
was above the RDA for both groups (1.4 and 1.1 g/kg bw/d for protein
and placebo group, respectively). No significant differences in hip and
femoral neck BMD between women in the protein or placebo group
after 1 and 2 years of protein supplementation were found. Hip and
femoral neck BMD in both groups fell significantly from baseline.
3.4. Meta-analysis
A meta-analysis could be conducted for the outcome hip fracture
among four cohort studies including eight different groups (Fig. 2).
The study of Cauley et al. [24] was excluded from the meta-analysis,
since the same cohort populationwas used as in the study of Langsetmo
et al. [30]. The latter was preferred because the follow-up duration was
longer. The association between protein intake and risk of hip fracture
was expressed as weighted HR (RR reported in one study was consid-
ered as HR). HR was transformed to its natural logarithm (ln) and the
corresponding 95% CIs were used to calculate the standard errors. In-
verse variance weighting was used to obtain the pooled HR for higher
compared to lower protein intakes. Heterogeneity was not significantly
present for hip fracture (I2 = 0.0%, heterogeneity chi-squared p =
0.614) and a fixed-effect model was used. The meta-analysis of the
Table 6
Quality of evidence per outcome of interest from selected studies.
Outcome Number of cohort studies Number of RCTs Risk of bias Imprecision Consistency Number of moderate quality studies Overall quality rating
BMC - total body 2 0 Some concerns Some concerns 1 p, 1 ns 0 Very low
BMD
Total body 4 0 Low Low 1 p, 3 ns 1 Low
Total hip 5 1 Some concerns Low 2 p, 3 ns 1 Low
Femoral neck 6 1 Some concerns Low 3 p, 3 ns 1 Low
Lumbar spine 4 0 Some concerns Low 1 p, 1 n, 2 ns 1 Low
Bone turnover markers
Osteocalcin 2 0 Some concerns Some concerns 2 ns 0 Very low
N-telopeptide 2 0 Some concerns Some concerns 2 ns 0 Very low
Fracture
Total 1 0 Low Low 1 ns 0 Very low
Spine 1 0 Low Low 1 ns 1 Very low
Hip 5 0 Low Low 4 p, 1 ns 2 Low
Note. According to theGRADE approach, evidencewas graded as ‘High’, ‘Moderate’, ‘Low’, or ‘Very Low’ depending on several criteria. Risk of bias is a combined judgement from risk of bias
in the individual studies. Indirectnesswas rated low for all outcomes. BMC=BoneMineral Content; BMD=BoneMineral Density; n=negative; ns=not significant; p=positive; RCT=
Randomized Controlled Trial.
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tistically significant decrease in hip fractures (pooled HR: 0.89; 95% CI:
0.84, 0.94; pb0.001).
Sensitivity analyses showed that there was no single study affecting
the overall estimate considerably. A subgroup analysis was performed
for gender. One study had to be excluded because no separate data
was available for men and women [22]. A pooled HR of 0.82 (95% CI:
0.73, 0.93; p = 0.002) was found for men and 0.91 (95% CI: 0.86, 0.98;
p = 0.007) for women. This difference was not statistically different
(p = 0.126).
Meta-analyses with other outcomes of interest could not be per-
formed, because missing quantitative data could not be provided for
each relevant article after contact with authors.4. Discussion
The aim of this systematic review and meta-analysis was to investi-
gate the impact of a dietary protein intake above the RDA of 0.8 g/kg
body weight/day from any source on BMD/BMC, bone turnover mark-
ers, and fracture risk in older adults compared to a lower dietary protein
intake. Our findings showed a positive trend between higher protein in-
takes and higher femoral neck and total hip BMD. Conflicting results
were reported for lumbar spine BMD and no association was found for
total body BMD. No conclusions could be drawn regarding BMC and
bone turnover markers. Meta-analysis of four prospective cohort stud-
ies showed a statistically significant decrease of 11% in hip fracture risk.Fig. 2. Effect of protein intake on hip fractures. Fixed-effect pooled hazard ratio (HR) analysis w
weight of the study.Horizontal lines depict the length of the 95% CI. Thediamond represents the
of the effect at specific age levels (65 and 75 y) selected from a continuous distribution. Total sTotal body BMC was measured in only two cohort studies, of which
one had a high risk of bias [31] and the other one had imprecise results
[29]. Therefore, quality of evidence for total body BMCwas rated as very
low. Quality of evidence for the bone turnovermarkerswas also rated as
very low due to eligibility of only two cohort studies, of which one was
rated down due imprecision [32]. Risk of bias of the other cohort studies
did not affect the quality of evidence.
The selected cohort studies compared varying levels of protein in-
takes, whichmakes comparisons between studies difficult and it can in-
fluence themagnitude of the measured effect. In addition, some studies
looked at very high levels above the RDA, while others reported protein
intakes closer to the RDA. For instance, two studies divided the protein
intake in tertiles with the highest protein category being N1.6 g/kg bw/d
[27,31] and the highest category in the study of Fung et al. was 1.4 g/kg
bw/d. While in three other cohort studies, the highest protein category
was around1.2 g/kg bw/d [22,26,29]. Rapuri et al. dividedprotein intake
in four quartiles, which were very close to each other when transferred
frompercentage of energy intake to g/kg bw/d as unit. Thisminimal dif-
ference in protein intakemay be one of the reasonswhy in this study no
significant differences in bone health outcomes were found.
No sufficient evidence was available from intervention studies, only
one RCT was eligible for inclusion in this review. This RCT showed no
significant difference in hip and femoral neck BMD between protein
and placebo group after 2 years. However, these outcomes fell signifi-
cantly from baseline in both groups. Since protein intake after 2 years
was above the RDA for both groups, this may indicate that a protein in-
take above the RDA is beneficial for hip and femoral neck BMD. This is inas used. Grey boxes represent the point estimates with the size of the box representing the
pooled effect estimate. * No exact sample size can be stated; thehazard ratio is the estimate
ample size was 144,580 persons.
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showed no differences and 2 showed beneficial differences) and femo-
ral neck BMD (3 studies showed no differences and 3 showed beneficial
differences). The overall risk of bias in this RCT was classified as low to
some concerns. Since this study was only done in women, representa-
tiveness is limited.
Over the years, several systematic reviews and meta-analyses
assessing the impact of protein intake on bone health have been
published. Darling et al. (2009) investigated the effect of varying
protein intakes in healthy adults of 18 years and older and included
31 observational studies and 19 RCTs [8]. They concluded that there
might be a small beneficial effect of protein supplementation on
lumbar spine BMD (weighted mean difference = 0.02 g/cm2; 95%
CI: 0.00, 0.04), but that it is unknown if this also results in a reduced
fracture risk. However, they also included studies with a duration of
b6 months, leading to a less a reliable estimate of the impact on
changes in BMD [12]. In comparison with the current review, we
did not have enough data to assess lumbar spine BMD. We did find
an effect on hip fracture risk, which can partly be explained by the
differences between study populations (adults ≥18 years vs adults
≥65 years).
A more recent systematic review of Shams-white et al. [9] investi-
gated the effect of varying protein intakes in healthy adults of 18 years
and older and excluded studies with a duration of b6 months [9]. A
total of 20 observational studies and 16 RCTs were included, which
showed that therewere positive trends of high compared to lowprotein
intakes on BMD at different bone sites, especially the lumbar spine (net
percentage change = 0.52%; 95% CI: 0.06, 0.97). Meta-analyses of RCTs
assessing lumbar spine, total hip and femoral neck BMD were
performed; no meta-analysis was done with hip fracture risk. Since in-
sufficient evidence is available from RCTs in the current review, meta-
analysis results cannot be compared.
The systematic review of Wallace & Frankenfeld [10] included
healthy adults of 18 years and older and specifically focused on protein
intakes above the current RDA [10]. They also excluded weight loss
studies and studies in which women used hormone replacement ther-
apy (HRT), resulting in the inclusion of 15 observational studies and
16 RCTs. They conclude that a protein intake above 0.8 g/kg body
weight/day can potentially have a beneficial effect on hip fracture risk
(pooled RR= 0.84; 95% CI: 0.73, 0.95) and BMD loss (qualitative evalu-
ation). Although this meta-analysis included a younger population, the
reduction in hip fracture risk is similar towhatwe have found. They also
included studies with a duration of b6 months, leading to a less a reli-
able estimate of the impact on changes in BMD [12]. Therefore, results
for BMD outcomes cannot be compared.
Lastly, results of themeta-analysis performed byWu et al. [34] were
the same as the currentmeta-analysis: a significant decrease in hip frac-
ture risk of 11% (RR 0.89; 95% CI 0.82, 0.97) [34]. Two of the six included
prospective cohort studies were also added to the current meta-
analysis, the other four were performedwith adults aged b65 years. De-
spite addition of recent publications investigating older adults in our
analysis, no differences in hip fracture risk reduction could be observed.
The prevalence of osteoporosis and fracture risk are higher in
women than in men [35,36]. Therefore, the effect of a high protein in-
take on hip fracture risk may be gender-specific. However, subgroup
analysis for gender showed no statistically significant difference in hip
fracture risk reduction and therefore it was assumed that pooling the ef-
fect of men and women together was fair. Currently, much research is
focused on postmenopausal women, but since men tend to have a
higher mortality risk after a fracture, men should not be overlooked
[36,37].
Previously it was believed that a high dietary protein intake could
have a negative effect on bone health by inducing chronic metabolic ac-
idosis, which eventually leads to osteoporosis [38]. However, an in-
crease in urinary calcium excretion observed after a high protein diet
likely originates from an increased intestinal absorption instead offrom bone calcium loss [39]. In addition, an expert consensus paper
from 2018, assessing the risks and benefits of dietary protein for bone
health, concluded that a protein intake above the RDA is beneficial for
older adults [3]. A long-term protein intake of 2 g/kg body weight/day
is reported safe for healthy adults, higher values may lead to digestive,
renal, and vascular problems [40]. No conclusive evidence is available
to set a new RDA for older adults in the light of bone health.
Two comments must be made with respect to the study eligibility
criteria of the current review. In the pre-specified protocol, it was men-
tioned that studies including women using oral contraceptives or HRT
would be excluded, except when stratification was done or when it
was controlled for in the analyses. In principle, women aged ≥65 years
do not take oral contraceptives anymore. Regarding HRT, a majority of
the included studies did not report if women used this. Since we have
older adults as study population, exclusion of this group of people
might harm the generalizability. Therefore, we decided to remove this
exclusion criterion. Secondly, it was stated that vegan individuals
would be excluded, but this was not reported in the included studies.
We assumed that the prevalence of vegan individuals in this generation
is negligible [41] and therefore the expected impact on the results is
minimal.
For the meta-analysis, standard errors were estimated from the
HR or RR and its 95% CI, reported by the individual studies. When
standard errors were back transformed to CIs, this indirect vari-
ance estimation resulted into a close but not similar value of the
actually reported CIs. However, the differences were small (maxi-
mum interval difference of 0.02) and assumed not to influence the
results.
A strength of this study was that only studies investigating older
adults (aged ≥65 years) were included, making the recommendation
specific for this more vulnerable group that has a greater protein
need than younger adults. As a consequence, the review is limited
by inclusion of only one intervention study. This makes clear that
large and long-term RCTs in older adults are needed to judge if a pro-
tein intake above the current RDA can improve bone health and/or
prevent osteoporosis. Another strength was the exclusion of studies
with a duration of b6 months, studies that supplemented protein in
the form of soy isoflavone, and studies designed for weight loss.
These exclusion criteria eliminate a proportion of confounding
issues.
5. Conclusions
This systematic review supports that there is an association between
a dietary protein intake above the current RDA of 0.8 g/kg bodyweight/
day and a reduced hip fracture risk in older adults. In addition, positive
trends for total hip and femoral neck BMD were found. In comparison
with younger adults, the body of evidence from the included studies is
not strong enough to increase the protein recommendation for older
adults with respect to bone health.
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